European Molecular Diagnostics Market 2015 - Forecasts to 2020

May 19, 2015, 06:37 ET from Research and Markets

DUBLIN, May 19, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/8wz8jq/2015_european) has announced the addition of the "2015 European Molecular Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies--Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing" report to their offering.

This new 970-page comprehensive five-country report from a is designed to help current suppliers and potential market entrants identify and evaluate the major business opportunities emerging in the European molecular diagnostics market during the next five years. The report explores business and technological trends in major European countries (France, Germany, Italy, Spain, UK); provides 5-year test volume/sales forecasts; estimates shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.

The $4.5 billion molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of and cost-effective automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostics companies during the next five years.

Key Topics Covered:

I. Introduction

II. Worldwide Technology and Market Overview

III. France

IV. Germany

V. Italy

VI. Spain

VII. U.K.

VIII. Major Product Development Opportunities

IX. Design Criteria for Decentralized Testing Products

X. Alternative Market Penetration Strategies

XI. Potential Market Entry Barriers and Risks

XII. Competitive Assessments

XIII. Appendix

Companies Mentioned

- Abbott
- Affymetrix
- Agilent
- Applied Gene Technologies
- Arca
- Beckman Coulter/Danaher
- Becton Dickinson
- Biokit
- BioMerieux
- Bio-Rad
- Caliper
- Cepheid
- Decode
- Diadexus
- Eiken
- Enzo
- Exact Sciences
- Innogenetics/Solvay
- Kreatech
- Li-Cor Biosciences
- Life Technologies
- Monogram Biosciences
- Myriad Genetics
- Nanogen/Elitech
- Novartis
- Orchid CellMark
- Ortho-Clinical Diagnostics
- Proteome Sciences
- Qiagen
- Roche
- Scienion
- Sequenom
- Shimadzu
- Siemens
- Tecan Group

For more information visit http://www.researchandmarkets.com/research/8wz8jq/2015_european

Media Contact:

Laura Wood , +353-1-481-1716, press@researchandmarkets.net



SOURCE Research and Markets



RELATED LINKS

http://www.researchandmarkets.com